PATENT CLAIM ANALYSIS

Application Number: 16103264
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "397000"]

Abstract:
The invention relates to the field of medicine and concerns an agent that stimulates tissue regeneration and the recovery of diminished tissue and organ function. A medicinal agent for the treatment and/or prophylaxis of a pathological condition selected from the group including metabolic syndrome, impaired glucose tolerance, hepatitis, particularly chronic hepatitis and toxic hepatitis, idiopathic pulmonary fibrosis (IPF), emphysema of the lungs, chronic obstructive pulmonary disease (COPD) and cachexia, particularly as a result of impaired glucose tolerance, pulmonary fibrosis, chronic obstructive pulmonary disease, cancer and other diseases, is proposed in the form of an agent based on Treamide. The latter is a bisamide derivative of dicarboxylic acid of formula (I) or a pharmaceutically acceptable salt thereof.

Claim (Index 4):
The method of  claim 3 , wherein the prostatitis is chronic prostatitis, in particular abacterial chronic prostatitis; or category 3B prostatitis, or autoimmune prostatitis.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 96.0
- Lexical Diversity: 1.7
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15576387', '15626774', '14638763', '11892595', '11505499']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7157472612746404
- 35 USC 102 Novelty (BERT): 0.5869081632831359
- Combined Prediction Score: 0.70286335147549
- Mean Citation Score: 329.5447000000001
- Max Citation Score: 627.86176
- Similarity Product: 357.2398351573944

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test